Highlights from ASCO 2024

Join medical experts Dr. Yuan and Dr. Gerber to learn about breast and ovarian cancer treatment updates form the 2024 American Society of Clinical Oncology Annual Meeting.

Register here.

For questions, please contact Rachel Teicher, LSW at [email protected].

Thank you to our sponsor

Speaker Bios

Dr. Yuan Yuan, MD, PhD
Director, Breast Oncology, Medical Director, Cedars-Sinai Comprehensive Cancer Institute

Dr. Yuan Yuan, MD, PhD, is a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer immunotherapy. Yuan, whose training includes a fellowship in hematology and medical oncology at New York University Medical Center and a rotation at Memorial Sloan Kettering Cancer Center in New York, received her medical degree in China and holds a PhD in biochemistry and molecular biology from the University of California, Riverside. Yuan’s research focus is triple-negative breast cancer, a fast-growing and often aggressive form of the disease.

To that end, Yuan’s research aims to expand the number of triple-negative breast cancer patients who can benefit from immune checkpoint inhibitors–a number that currently stands at just 30 percent. She and her team are testing a novel immunotherapy combination to turn “immune-cold” tumors, which cannot be penetrated by the body’s immune system, into “immune-hot” tumors that readily respond to immunotherapies. She is also working closely with the Cedars-Sinai cell therapy team to bring first-in-class immunotherapy treatments to patients with solid tumors, including breast cancers. Yuan, who most recently served as medical director of breast cancer immunotherapy at City of Hope, speaks Mandarin and places patient care front and center.

Dr. Gerber

For as long as I can remember, I was on the path to becoming a doctor who specialized in women’s health. My passion has always been to care for and empower women who are going through difficult times. Gynecologic oncology is the perfect field for me because I get to form strong relationships with patients and their families throughout the course of treatment.

I treat women who have cancer of the reproductive tract, including endometrial, ovarian, cervical, vaginal, and vulvar cancer. I also treat women who have been diagnosed with a genetic mutation that increases their risk of gynecologic cancer. To help reduce this risk, I offer preventive treatments and risk-reducing surgery.

I specialize in minimally invasive laparoscopic and robotic-assisted surgery, as well as extensive debulking procedures to remove tumors. After several years of specialized surgical training, I am comfortable creating optimal surgical plans to remove extensive gynecologic cancers. After surgery, I form a plan for further treatment or follow-up care based on the diagnosis.

My aim is to treat every patient as an individual and each of my patients receives personalized evaluation, diagnosis, and treatment. At NYU Langone Hospital–Long Island, we believe in a holistic approach to treatment which includes collaborating with other specialties and services. I work with a team of gynecologic oncologists, pathologists, radiation oncologists, medical oncologists, genetic counselors, physician assistants, nurses, social workers, and radiologists. As part of Perlmutter Cancer Center, we have a large clinical trial portfolio available to our patients who have gynecologic cancers. These include novel immunotherapy options and targeted therapy combinations. There are always new developments in our field, and we aim to provide innovative care to all of our patients.

A cancer diagnosis can lead to fear and confusion. My aim is to alleviate those concerns and pay close attention to each woman’s unique medical, social, and psychosocial needs. Though my goal is to optimize care and eliminate cancer, I strongly believe in maintaining a good quality of life while doing so.

Disclaimer:

By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.